313 related articles for article (PubMed ID: 17133163)
41. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
[TBL] [Abstract][Full Text] [Related]
42. Cholera outbreak in southeast of iran: routes of transmission in the situation of good primary health care services and poor individual hygienic practices.
Izadi S; Shakeri H; Roham P; Sheikhzadeh K
Jpn J Infect Dis; 2006 Jun; 59(3):174-8. PubMed ID: 16785698
[TBL] [Abstract][Full Text] [Related]
43. Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.
Benenson AS; Saad A; Mosley WH; Ahmed A
Bull World Health Organ; 1968; 38(2):287-95. PubMed ID: 5302304
[TBL] [Abstract][Full Text] [Related]
44. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
Khan MU; Barua DK; Begum T; Shahidullah M
Trop Geogr Med; 1987 Jul; 39(3):271-5. PubMed ID: 3433343
[TBL] [Abstract][Full Text] [Related]
45. Cytokines and soluble CD14 in breast milk in relation with atopic manifestations in mother and infant (KOALA Study).
Snijders BE; Damoiseaux JG; Penders J; Kummeling I; Stelma FF; van Ree R; van den Brandt PA; Thijs C
Clin Exp Allergy; 2006 Dec; 36(12):1609-15. PubMed ID: 17177685
[TBL] [Abstract][Full Text] [Related]
46. Detection of IgE anti-parvovirus antibodies in human breast milk.
Smith-Norowitz TA; Drew H; Norowitz HM; Nowakowski M; Bluth EF; Durkin HG; Bluth MH
Ann Clin Lab Sci; 2008; 38(2):168-73. PubMed ID: 18469364
[TBL] [Abstract][Full Text] [Related]
47. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
[TBL] [Abstract][Full Text] [Related]
48. A longitudinal study of infant feeding and obesity throughout life course.
Michels KB; Willett WC; Graubard BI; Vaidya RL; Cantwell MM; Sansbury LB; Forman MR
Int J Obes (Lond); 2007 Jul; 31(7):1078-85. PubMed ID: 17452993
[TBL] [Abstract][Full Text] [Related]
49. Transmission of West Nile virus through human breast milk seems to be rare.
Hinckley AF; O'Leary DR; Hayes EB
Pediatrics; 2007 Mar; 119(3):e666-71. PubMed ID: 17332186
[TBL] [Abstract][Full Text] [Related]
50. Protection from cholera by adding lime juice to food - results from community and laboratory studies in Guinea-Bissau, West Africa.
Rodrigues A; Sandström A; Cá T; Steinsland H; Jensen H; Aaby P
Trop Med Int Health; 2000 Jun; 5(6):418-22. PubMed ID: 10929141
[TBL] [Abstract][Full Text] [Related]
51. Cholera epidemic associated with raw vegetables--Lusaka, Zambia, 2003-2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(34):783-6. PubMed ID: 15343144
[TBL] [Abstract][Full Text] [Related]
52. [Effect of breastfeeding on the risk of becoming overweight in offspring of mothers with type 1 diabetes].
Kreichauf S; Pflüger M; Hummel S; Ziegler AG
Dtsch Med Wochenschr; 2008 May; 133(22):1173-7. PubMed ID: 18491272
[TBL] [Abstract][Full Text] [Related]
53. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
[TBL] [Abstract][Full Text] [Related]
54. Serological studies in cholera infection in Calcutta (1966-67).
Deb BC; Ganguly R; Sinho R; Ghosh AK; Succar BK; Abou-Gareeb AH; Ozawa A; Shrivastava DL; Burrows W
Indian J Med Res; 1973 Feb; 61(2):169-78. PubMed ID: 4758991
[No Abstract] [Full Text] [Related]
55. [Cholera in a district of Peru].
Pérez Rodríguez AE; Monté Boada R; de la Vega Díaz JE; Molina R; García Gómez V; Arca González JM
Rev Cubana Med Trop; 1996; 48(3):204-8. PubMed ID: 9805053
[TBL] [Abstract][Full Text] [Related]
56. Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.
Ali M; Emch M; Yunus M; Sack D; Lopez AL; Holmgren J; Clemens J
Pediatr Infect Dis J; 2008 Jan; 27(1):33-7. PubMed ID: 18162935
[TBL] [Abstract][Full Text] [Related]
57. A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.
Mosley WH; Benenson AS; Barui R
Bull World Health Organ; 1968; 38(3):327-34. PubMed ID: 5302327
[TBL] [Abstract][Full Text] [Related]
58. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
[TBL] [Abstract][Full Text] [Related]
59. First do no harm: making oral rehydration solution safer in a cholera epidemic.
Daniels NA; Simons SL; Rodrigues A; Gunnlaugsson G; Forster TS; Wells JG; Hutwagner L; Tauxe RV; Mintz ED
Am J Trop Med Hyg; 1999 Jun; 60(6):1051-5. PubMed ID: 10403342
[TBL] [Abstract][Full Text] [Related]
60. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease.
Grönlund MM; Gueimonde M; Laitinen K; Kociubinski G; Grönroos T; Salminen S; Isolauri E
Clin Exp Allergy; 2007 Dec; 37(12):1764-72. PubMed ID: 17941914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
